IPAs are facing a backlash, but with a little hunting you can find some examples of the style that are well worth celebrating!
NYS Entity Status
NYS Filing Date
MARCH 28, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - MERIDIANRX IPA LLC
Around the Web
- Celebrate National IPA Day By Chasing Down The Best IPAs On The Market
By Zachary Johnston - Thursday Aug 3, 2017
- Are IPAs Giving You Man Boobs?
By Dan Seitz - Friday Sep 1, 2017
IPAs are rich in phytoestrogens, which are good for you! But are they also, as some claim, giving men breasts?
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Sports calendar, July 4-5
Wednesday Jul 5, 2017
Sports calendar, July 4-5BaseballN.Y. Mets at Washington MLBNetGiants at Detroit NBCSBA (680)Toronto at N.Y. Yankees (1050) MLBNet joins in progress at 11 a.m.Chicago White Sox at A’s NBCSCA (95.7)Pittsburgh at Philadelphia ESPNBoston at Texas ESPNMinors:Rancho Cucamonga atCyclingTour de France, Stage 4 NBCSNHorse racingSoccerMLS:Earthquakes at Atlanta NBCSBA (1050)TennisWimbledon ESPNBaseballToronto at N.Y. Yankees MLBNetChicago White Sox at A’s NBCSCA (95.7)Giants at Detroit NBCSBA (680)N.Y. Mets at Washington ESPNArizona at L.A. Dodgers MLBNetMinors:Rancho Cucamonga atBasketballPro-Am:Dream Team vs.South Bay, Kezar PavilionCyclingTour de France, Stage 5 NBCSNGolfPGA Europe:TennisWimbledon ESPN
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]